This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
VidaMed (devices for the treatment of benign prostatic hyperplasia) has netted about $18 million in an IPO of 3.1 million shares at $6.50 per share. When the offering was registered in May, the company intended to sell 2.5 million share at $10 each.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?